Related Experiment Video
Updated: Aug 14, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Elevated LDL Triglycerides and Atherosclerotic Risk
Mie Balling1, Shoaib Afzal1, George Davey Smith2
1Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark; The Copenhagen General Population Study, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Insights
Elevated low-density lipoprotein (LDL) triglycerides significantly increase the risk of atherosclerotic cardiovascular disease (ASCVD) and its components. This finding was consistent across two cohort studies and meta-analyses, confirming a robust association.
Area of Science:
- Cardiovascular Medicine and Epidemiology
- Lipid Metabolism and Atherosclerosis Research
Background:
- The association between elevated low-density lipoprotein (LDL) triglycerides and the risk of atherosclerotic cardiovascular disease (ASCVD) remains incompletely understood.
- Clarifying this relationship is crucial for refining cardiovascular risk assessment and prevention strategies.
Purpose of the Study:
- To investigate the hypothesis that elevated LDL triglycerides are significantly associated with an increased risk of ASCVD.
- To determine the association of elevated LDL triglycerides with individual components of ASCVD, including ischemic heart disease, myocardial infarction, ischemic stroke, and peripheral artery disease.
Main Methods:
- Utilized data from the Copenhagen General Population Study, measuring LDL triglycerides via direct automated assay (n=38,081) and NMR spectroscopy (n=30,208).
- Conducted meta-analyses combining findings from the current study with previously published research.
- Employed Cox proportional hazards models to assess hazard ratios (HRs) for ASCVD events per unit increase in LDL triglycerides.
Main Results:
- A significant positive association was observed between higher direct LDL triglycerides and increased risk for ASCVD (HR=1.26), ischemic heart disease (HR=1.27), myocardial infarction (HR=1.28), ischemic stroke (HR=1.22), and peripheral artery disease (HR=1.38).
- Similar associations were found with NMR LDL triglycerides, indicating robust risk prediction across different measurement methods.
- Meta-analyses confirmed these findings, with the highest quartile of LDL triglycerides showing a 1.50-fold increased risk for ASCVD compared to the lowest quartile.
Conclusions:
- Elevated LDL triglycerides are robustly associated with a significantly increased risk of developing ASCVD and its individual components.
- These findings underscore the importance of monitoring and managing LDL triglycerides as a critical factor in cardiovascular disease prevention.
Background:
It is unclear whether elevated low-density lipoprotein (LDL) triglycerides are associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD).
Objectives:
This study tested the hypothesis that elevated LDL triglycerides are associated with an increased risk of ASCVD and of each ASCVD component individually.
Methods:
The study investigators used the Copenhagen General Population Study, which measured LDL triglycerides in 38,081 individuals with a direct automated assay (direct LDL triglycerides) and in another 30,208 individuals with nuclear magnetic resonance (NMR) spectroscopy (NMR LDL triglycerides). Meta-analyses aggregated the present findings with previously reported results.
Results:
During a median follow-up of 3.0 and 9.2 years, respectively, 872 and 5,766 individuals in the 2 cohorts received a diagnosis of ASCVD. Per 0.1 mmol/L (9 mg/dL) higher direct LDL triglycerides, HRs were 1.26 (95% CI: 1.17-1.35) for ASCVD, 1.27 (95% CI: 1.16-1.39) for ischemic heart disease, 1.28 (95% CI: 1.11-1.48) for myocardial infarction, 1.22 (95% CI: 1.08-1.38) for ischemic stroke, and 1.38 (95% CI: 1.21-1.58) for peripheral artery disease. Corresponding HRs for NMR LDL triglycerides were 1.26 (95% CI: 1.20-1.33), 1.33 (95% CI: 1.25-1.41), 1.41 (95% CI: 1.31-1.52), 1.13 (95% CI: 1.05-1.23), and 1.26 (95% CI: 1.10-1.43), respectively. The foregoing results were not entirely statistically explained by apolipoprotein B levels. In meta-analyses for the highest quartile vs the lowest quartile of LDL triglycerides, random-effects risk ratios were 1.50 (95% CI: 1.35-1.66) for ASCVD (4 studies; 71,526 individuals; 8,576 events), 1.62 (95% CI: 1.37-1.93) for ischemic heart disease (6 studies; 107,538 individuals; 9,734 events), 1.30 (95% CI: 1.13-1.49) for ischemic stroke (4 studies; 78,026 individuals; 4,273 events), and 1.53 (95% CI: 1.29-1.81) for peripheral artery disease (4 studies; 107,511 individuals; 1,848 events).
Conclusions:
Elevated LDL triglycerides were robustly associated with an increased risk of ASCVD and of each ASCVD component individually in 2 prospective cohort studies and in meta-analyses of previous and present studies combined.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...

